 GAITHERSBURG, Md., Feb. 22, 2021 GLOBE NEWSWIRE -- Viela Bio Nasdaq:VIE, a biotechnology company dedicated to the discovery, development and commercialization of novel treatments for patients suffering from autoimmune and severe inflammatory diseases, today announced it will report its fourth quarter and full year 2020 operating and financial results after the U.S. financial markets close on Monday, March 1, 2021. 